Patents by Inventor Marie-Anne Petit

Marie-Anne Petit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions
    Publication number: 20150239959
    Abstract: Antibodies and antigen-binding molecules directed against Hepatitis C virus (HCV) are presented. The antibodies and antigen-binding molecules specifically bind to the HCV E1E2 complex. Also provided are pharmaceutical compositions containing the antibodies and/or antigen-binding molecules. Nucleic acids encoding the antibodies and antigen-binding molecules, along with corresponding expression vectors and host cells are also provided.
    Type: Application
    Filed: May 8, 2015
    Publication date: August 27, 2015
    Inventors: Marie Anne PETIT, Emmanuel DROUET, Christian TREPO
  • Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions
    Publication number: 20130052187
    Abstract: New conformational antibodies, and more particular conformational monoclonal antibodies and fragments thereof, are directed against HCV. Also provided are compositions of particles that are recognized by such antibodies, and pharmaceutical compositions containing these particles. Also described are HCV enveloped subviral particles and purified HCV enveloped complete viral particles, as well as processes for their preparation.
    Type: Application
    Filed: September 14, 2012
    Publication date: February 28, 2013
    Applicants: INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), Universite Joseph Fourier (Grenoble), BIOMERIEUX SA
    Inventors: Marie Anne PETIT, Emmanuel DROUET, Christian TREPO
  • ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS E1E2 COMPLEX, COMPOSITIONS OF HCV PARTICLES, AND PHARMACEUTICAL COMPOSITIONS
    Publication number: 20110311551
    Abstract: The invention provides new conformational antibodies, and more particular conformational monoclonal antibodies and fragments thereof, that are directed against HCV. Also provided are compositions of particles that are recognized by such antibodies, and pharmaceutical compositions containing these particles. Also described are HCV enveloped subviral particles and purified HCV enveloped complete viral particles, as well as processes for their preparation.
    Type: Application
    Filed: May 24, 2011
    Publication date: December 22, 2011
    Inventors: Marie Anne PETIT, Emmanuel DROUET, Christian TREPO
  • Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
    Patent number: 8007792
    Abstract: New conformational antibodies are directed against HCV and more particularly to monoclonal antibodies. Described compositions of particles are liable to be recognized by the antibodies, as are pharmaceutical compositions containing them. Also described are HCV enveloped subviral particles or purified HCV enveloped complete viral particles, and the processes for preparing them.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: August 30, 2011
    Assignees: INSERM, Biomerieux SA
    Inventors: Marie-Anne Petit, Colette Jolivet-Reynaud, Christian Trepo
  • ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS E1E2 COMPLEX, COMPOSITIONS OF HCV PARTICLES, AND PHARMACEUTICAL COMPOSITIONS
    Publication number: 20090186023
    Abstract: New conformational antibodies are directed against HCV and more particularly to monoclonal antibodies. Described compositions of particles are liable to be recognized by the antibodies, as are pharmaceutical compositions containing them. Also described are HCV enveloped subviral particles or purified HCV enveloped complete viral particles, and the processes for preparing them.
    Type: Application
    Filed: March 20, 2009
    Publication date: July 23, 2009
    Inventors: Marie-Anne Petit, Colette Jolivet-Raynaud
  • Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
    Patent number: 7524650
    Abstract: New conformational antibodies are directed against HCV and more particularly to monoclonal antibodies. Described compositions of particles are liable to be recognized by the antibodies, as are pharmaceutical compositions containing them. Also described are HCV enveloped subviral particles or purified HCV enveloped complete viral particles, and the processes for preparing them.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: April 28, 2009
    Assignees: INSERM, Biomerieux SA
    Inventors: Marie-Anne Petit, Colette Jolivet-Reynaud
  • Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions
    Publication number: 20070026003
    Abstract: New conformational antibodies are directed against HCV and more particularly to monoclonal antibodies. Described compositions of particles are liable to be recognized by the antibodies, as are pharmaceutical compositions containing them. Also described are HCV enveloped subviral particles or purified HCV enveloped complete viral particles, and the processes for preparing them.
    Type: Application
    Filed: March 31, 2004
    Publication date: February 1, 2007
    Inventors: Marie-Anne Petit, Colette Jolivet-Reynaud